What is the management approach for a patient with a large vessel stroke and intracranial atherosclerotic disease (ICAD) presenting with a mild stroke, as indicated by a National Institutes of Health Stroke Scale (NIHSS) score of 5, and would Tirofiban (Aggrastat) be considered as a treatment option?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board

Educational purpose only • Exercise caution as content is pending human review

Article Review Status

Submitted

Under Review

Approved

Last updated: January 15, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Related Questions

What is the initial management for patients with large vessel occlusions and Intracranial Atherosclerotic Disease (ICAD) presenting with a National Institutes of Health Stroke Scale (NIHSS) score of more than 5, specifically regarding the use of Tirofiban (Aggrastat)?

What is the next step in therapy for a patient presenting with symptoms of a stroke, last seen normal 5 hours ago, with a large vessel occlusion in an M1 distribution, no hemorrhage on CT brain scan, normal glucose, hypertension, and an National Institutes of Health Stroke Scale (NIHSS) score of 8?

What is the role of intravenous (IV) tirofiban in the management of large vessel occlusion?

Which intracranial vessels are suitable for thrombectomy?

Which large vessel occlusion is amenable to thrombectomy?

What is the recommended treatment approach for a patient with sarcoma and lymph node (LN) spread, likely with elevated Lactate Dehydrogenase (LDH) levels?

How to diagnose serotonin syndrome in a patient with a history of depression, anxiety, hyperthyroidism, or menopause, taking Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs), or Monoamine Oxidase Inhibitors (MAOIs)?

What is the management for a patient with anemia and thrombocytopenia?

What are the symptoms and management for an adult patient with a history of respiratory or cardiac conditions presenting with volume loss on chest X-ray (CXR)?

How is the TNM (Tumor, Node, Metastasis) staging system used to determine the extent of disease in a patient with soft tissue sarcoma, lymph node involvement, and elevated lactate dehydrogenase (LDH) levels?

Is annual imaging necessary for follow-up care in a patient with a resected paraganglioma (paraganglioma is a type of neuroendocrine tumor) of the stomach?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.